TipRanks
Denali Therapeutics (DNLI)
NASDAQ:DNLI
US Market
DNLI
Denali Therapeutics
RESEARCH TOOLSreports
Want to see DNLI full AI Analyst Report?

Denali Therapeutics (DNLI) Stock News & Sentiment

887 Followers
Denali’s DNL921 Trial: Early Alzheimer’s Safety Data That Could Shape Long-Term Upside
Premium
Company Announcements
Denali’s DNL921 Trial: Early Alzheimer’s Safety Data That Could Shape Long-Term Upside
2M ago
DNLI
Denali Therapeutics’ AVLAYAH Launch Reshapes Earnings Story
Premium
Company Announcements
Denali Therapeutics’ AVLAYAH Launch Reshapes Earnings Story
2M ago
DNLI
Analyst Reiterates Buy on Denali Therapeutics as AVLAYAH Launch Gains Traction and Alzheimer’s Pipeline Advances; $42 Price Target Maintained
Premium
Ratings
Analyst Reiterates Buy on Denali Therapeutics as AVLAYAH Launch Gains Traction and Alzheimer’s Pipeline Advances; $42 Price Target Maintained
2M ago
DNLI
Denali Therapeutics Sells Priority Review Voucher for Capital
Premium
Company Announcements
Denali Therapeutics Sells Priority Review Voucher for Capital
2M ago
8K
DNLI
Denali’s New Pompe Disease Trial Adds Depth to Its Rare Disease Pipeline
Premium
Company Announcements
Denali’s New Pompe Disease Trial Adds Depth to Its Rare Disease Pipeline
3M ago
DNLI
Denali Monetizes FDA Voucher to Advance CNS Pipeline
Premium
Company Announcements
Denali Monetizes FDA Voucher to Advance CNS Pipeline
4M ago
8K
DNLI
Denali Therapeutics Shareholders Back Board, Auditors, Executive Pay
Premium
Company Announcements
Denali Therapeutics Shareholders Back Board, Auditors, Executive Pay
4M ago
8K
DNLI
More DNLI News >

DNLI News on the Web

Denali Therapeutics Inc. at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
DNLI Stock Gains 33.1% in Three Months: Buy, Sell or Hold the Stock?
Zacks
Neutral
Denali Therapeutics (DNLI) Receives a Buy from J.P. Morgan
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Denali Therapeutics (DNLI) and SAB Biotherapeutics (SABS)
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Denali Therapeutics Sells Priority Review Voucher for Capital
TipRanks News
Neutral
Denali Therapeutics price target raised to $35 from $31 at Deutsche Bank
TipRanks News
Bullish
Jefferies Keeps Their Buy Rating on Denali Therapeutics (DNLI)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DNLI
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.75 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DNLI’s Media Buzz Sentiment?
1 articles about DNLI were published this week. In an average week, 0.75 articles are published.
    What is DNLI’s weekly average amount of articles?
    In an average week, 0.75 articles about DNLI are published.
      What is DNLI’s News Sentiment?
      50% of articles about DNLI were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        REGNRegeneron
        QTTBQ32 Bio
        NVSNovartis
        RHHVFRoche Holding AG
        KRROKorro Bio
        Showing the stocks with the most bullish news sentiment over the past week